Profound Medical Corp. (PROF) stock
PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.85+0.17 (+2.21%)
Close on Nov 11, 2026Market cap $286.78MP/E –Yield –
Profound Medical cash
Cash and short-term investments held at the end of each period.
Profound Medical's cash was $33.34M at Sep 30, 2026. For fiscal 2025 it was $59.72M, up 8.8% from the year before. The highest annual figure on record is $83.91M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $59.72M | +8.8% |
| FY2024 | Dec 31, 2024 | $54.91M | +109.5% |
| FY2023 | Dec 31, 2023 | $26.21M | -43.6% |
| FY2022 | Dec 31, 2022 | $46.52M | -30.7% |
| FY2021 | Dec 31, 2021 | $67.15M | -20.0% |
| FY2020 | Dec 31, 2020 | $83.91M | +467.0% |
| FY2019 | Dec 31, 2019 | $14.80M | -34.2% |
| FY2018 | Jan 1, 2019 | $22.50M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $33.34M | +34.3% |
| Q2 FY2026 | Jun 30, 2026 | $38.27M | +8.7% |
| Q1 FY2026 | Mar 31, 2026 | $50.30M | +8.3% |
| Q4 FY2025 | Dec 31, 2025 | $59.72M | +8.8% |
| Q3 FY2025 | Sep 30, 2025 | $24.83M | -8.5% |
| Q2 FY2025 | Jun 30, 2025 | $35.20M | +3.3% |
| Q1 FY2025 | Mar 31, 2025 | $46.43M | +12.8% |
| Q4 FY2024 | Dec 31, 2024 | $54.91M | +109.5% |
| Q3 FY2024 | Sep 30, 2024 | $27.12M | -41.7% |
| Q2 FY2024 | Jun 30, 2024 | $34.08M | -49.3% |
| Q1 FY2024 | Mar 31, 2024 | $41.18M | -50.9% |
| Q4 FY2023 | Dec 31, 2023 | $26.21M | +77.1% |
| Q4 FY2022 | Dec 31, 2022 | $46.52M | +106.8% |
| Q4 FY2021 | Dec 31, 2021 | $67.15M | – |
| Q4 FY2020 | Dec 31, 2020 | $83.91M | – |
| Q4 FY2019 | Dec 31, 2019 | $14.80M | – |
| Q4 FY2018 | Jan 1, 2019 | $22.50M | – |
See a number that looks wrong?